Model Number G247 |
Device Problems
Premature Discharge of Battery (1057); Failure to Capture (1081); Battery Problem (2885); High Capture Threshold (3266)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 01/30/2024 |
Event Type
Injury
|
Manufacturer Narrative
|
The product has been received for analysis.This report will be updated upon completion of analysis.
|
|
Event Description
|
It was reported that this cardiac resynchronization therapy defibrillator (crt-d) and right ventricular (rv) defibrillation lead exhibited non-capture at maximum outputs.The battery of this crt-d was suspected to be depleting prematurely due to a longevity estimate of 11 months less than a month after implant.The rv lead also exhibited low out-of-range pace impedance measurements less than 200 ohms.A request was made to have data from this device analyzed.Data analysis appeared consistent with a latent failure of the device pace output with the potential for lead corrosion.Chest x-rays appeared normal.This crt-d and rv lead were explanted, replaced, and returned for analysis.No additional adverse patient effects were reported.
|
|
Manufacturer Narrative
|
The product has been received for analysis.This report will be updated upon completion of analysis.Correction to h6: impact code f2203/imaging required added to indicate x-rays were performed.
|
|
Event Description
|
It was reported that this cardiac resynchronization therapy defibrillator (crt-d) and right ventricular (rv) defibrillation lead exhibited non-capture at maximum outputs.The battery of this crt-d was suspected to be depleting prematurely due to a longevity estimate of 11 months less than a month after implant.The rv lead also exhibited low out-of-range pace impedance measurements less than 200 ohms.A request was made to have data from this device analyzed.Data analysis appeared consistent with a latent failure of the device pace output with the potential for lead corrosion.Chest x-rays appeared normal.This crt-d and rv lead were explanted, replaced, and returned for analysis.No additional adverse patient effects were reported.
|
|
Search Alerts/Recalls
|